Építés alatt – nem éles oldal
Belépés
Résztvevőt keres itt: Egyesült ÁllamokFázis nélkül

Assessment of CSF Shunt Flow During Activities of Daily Living and Sleep With a Thermal Measurement Device

A legfontosabb adatok

Hol
Chicago és Richmond (Egyesült Államok)Mind a 2 helyszín megnézése

Helyszínek itt: Egyesült Államok

  • Rhaeos Inc.Chicago, Egyesült ÁllamokContact: Anna SomeraRésztvevőt keres
  • Virginia Commonwealth University Medical CenterRichmond, Egyesült ÁllamokContact: Lisa MerckRésztvevőt keres

Kérdések a vizsgálat csapatának

  1. Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
  2. Megtérítik az utazási költséget?
  3. Megtarthatom a saját orvosomat?
  4. Mi történik, ha ki akarok lépni?

Contact the study team: see the registry record → Contacts and Locations

Oldal nyomtatása az orvosomnak

A vizsgálat adatai

Ki végzi
Rhaeos, Inc.
Azonosító
NCT07050628
A regiszteradat frissítve
2026. augusztus 25.
Eredeti leírás
This study evaluates the performance of a device for non-invasively assessing cerebrospinal fluid (CSF) shunt flow over multiple measurements performed by a study subject during activities of daily living and sleepA teljes eredeti leírásKevesebb

Long-Term Tracking of Fluid Dynamics in Cerebrospinal Fluid Shunts With a Wireless Thermal Anisotropy Measurement Device During Activities of Daily Living Including Sleep

This study evaluates the performance of a device for non-invasively assessing cerebrospinal fluid (CSF) shunt flow over multiple measurements performed by a study subject during activities of daily living and sleep

Bevonási feltételek: Existing ventricular CSF shunt; (Cohort A) A history of stable ventricular size, no shunt revision in the previous 2 years, and no current symptoms of shunt failure; (Cohort B) A shunt revision in the previous 7 days and the investigator judges that the patient will likely be discharged within 4 days of the enrollment date; Region of intact skin overlying an unambiguously identifiable palpable chronically indwelling ventricular shunt which crosses the clavicle and is appropriate in size for application of the study device; Signed informed consent by subject or a parent, legal guardian, health care agent, or surrogate decision maker (according to local statutes); Subject is at least 5 years old but < 22 years old.

Kizáró feltételek: Use of the study device would interfere with standard patient care, or emergency surgery that cannot be delayed, or participation in the study will interfere with, or be detrimental to, administration of optimal healthcare to the subject; Prior enrollment in this study; Subject-reported history of serious adverse skin reactions to silicone-based adhesives; Shunt is not palpable or depth of shunt where the device will be placed is greater than 4 mm per ultrasound evaluation; Presence of an interfering open wound or edema in the study device measurement region; Investigator judges that the subject is likely to be lost to follow-up due to unavailability or clinical outcome being unobtainable; Investigator judges that the subject is unlikely to successfully take reliable measurements at home; Investigator judges that the subject/subject's caretaker would not be able to successfully place the device without assistance; Participation in any other investigational procedural, pharmaceutical, and/or device study that may influence the collection of valid data under this study.

ClinicalTrials.gov NCT07050628